Prefilled Syringes: Global Markets

Description

List of Tables

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

The global market for glass prefilled syringes is expected to grow from $11.0 billion in 2024 and is projected to reach $17.5 billion by the end of 2029, at a CAGR of 9.8% during the forecast period of 2024 to 2029.

The global market for plastic prefilled syringes is expected to grow from $3.5 billion in 2024 and is projected to reach $5.3 billion by the end of 2029, at a CAGR of 8.6% during the forecast period of 2024 to 2029.

Report Scope

The current report provides detailed information on the market for prefilled syringes. This report analyzes the market trends of prefilled syringes with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024 to 2029) and regional markets for prefilled syringes. This report will highlight prefilled syringes' current and future market potential and a detailed competitive environment analysis. The recent report will cover regulatory scenarios, drivers, restraints and opportunities. The report also covers market projections for 2029 and the market share for key players.

The market scope in this report is segmented into material, type, design and therapeutics. Based on materials, the report covers glass-based and polymer-based prefilled syringes. The market breakdown by type includes conventional and safety-prefilled syringes. The market is segmented based on design into single-chamber prefilled syringes, dual-chamber and customized prefilled syringes. The report reviews small molecules, heparins, vaccines and all other biologics in the therapeutics segment. It reviews the main prefilled syringe applications, which include arthritis, diabetes, cancer and others.

The market has been segmented into significant geographies, including North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Germany, the U.K., France, Japan, China and India. The market value is estimated for 2023, with forecasts for 2024 and 2029.

Report Includes

55 data tables and 29 additional tables
An updated review of the global markets for prefilled syringes
Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the current market's size and revenue growth prospects specific to prefilled syringes, along with a market share analysis by material, application, design, therapeutics, and geographic region
In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market
Assessment of major market drivers and opportunities estimating current and future demand for prefilled syringes, and key enabling technologies, and COVID-19 impact on the prefilled syringes
Discussion of key technology developments, latest trends, and other influential factors
Coverage of upcoming market opportunities and areas of focus to forecast this market into various segments and sub-segments
Insight into recent industry structure, current competitive scenario, R&D activities, and regulatory and legislative issues currently focused on medical industry
An analysis of key patents
Profiles of the leading players, including Becton Dickinson and Co., Baxter, Gerresheimer AG, Schott Pharma AG & Co. KGaA, and West Pharmaceuticals

Product Code: HLC223B

Chapter 1 Executive Summary

Market Outlook
Scope of the Report
Market Summary

Chapter 2 Market Overview

Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Market Restraints
Market Opportunities

Chapter 4 Regulatory and Reimbursement Landscape

Regulatory Scenario
U.S.
European Union
Japan
China
Reimbursement Landscape

Chapter 5 Product Pipeline for Prefilled Syringes

Overview

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Global Market for Prefilled Syringes, by Material
Global Market Size and Forecast
Glass Prefilled Syringes
Plastic Prefilled Syringes
Global Market for Prefilled Syringes, by Design
Global Market Size and Forecast
Single-Chamber Prefilled Syringes
Dual-Chamber Prefilled Syringes
Customized Prefilled Syringes
Global Market for Prefilled Syringes, by Therapeutics
Global Market Size and Forecast
Small Molecules
Monoclonal Antibodies
Vaccines
Other Therapeutics
Global Market for Prefilled Syringes, by Application
Global Market Size and Forecast
Diabetes
Cancer
Infectious Diseases
Other Applications
Geographic Breakdown
Global Market for Prefilled Syringes, by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World

Chapter 7 Competitive Intelligence

Competitive Landscape

Chapter 8 Sustainability in Prefilled Syringes: An ESG Perspective

Introduction to ESG
Sustainability in the Prefilled Syringes Market
Environmental Impact
Social Responsibility
Governance

Chapter 9 Appendix: Global Prefilled Syringes Market

Methodology
Abbreviations
Sources
Company Profiles
ARTE CORP.
BAXTER
BD
F. HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AG
HASELMEIER
NIPRO
SHL MEDICAL AG
STEVANATO GROUP
YPSOMED

Product Code: HLC223B

List of Tables

Summary Table : Global Market for Prefilled Syringes, by Material, Through 2029
Table 1 : Porter's Five Forces Analysis: Prefilled Syringes Market
Table 2 : Global Diabetes Prevalence, Estimates and Projections, 2019-2045
Table 3 : Global Prevalence of Multiple Sclerosis, by Region, 2013 and 2020
Table 4 : Global Population Growth, by Age Group, Through 2050
Table 5 : Product Pipeline for Prefilled Syringes
Table 6 : Global Market for Prefilled Syringes, by Material, Through 2029
Table 7 : Global Market for Glass Prefilled Syringes, by Region, Through 2029
Table 8 : Global Market for Plastic Prefilled Syringes, by Region, Through 2029
Table 9 : Global Market for Prefilled Syringes, by Design, Through 2029
Table 10 : Global Market for Single-Chamber Prefilled Syringes, by Region, Through 2029
Table 11 : Global Market for Dual-Chamber Prefilled Syringes, by Region, Through 2029
Table 12 : Global Market for Customized Prefilled Syringes, by Region, Through 2029
Table 13 : Global Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 14 : Global Market for Small Molecules, by Region, Through 2029
Table 15 : Global Market for Monoclonal Antibodies, by Region, Through 2029
Table 16 : Global Market for Vaccines, by Region, Through 2029
Table 17 : Global Market for Other Therapeutics, by Region, Through 2029
Table 18 : Global Market for Prefilled Syringes, by Application, Through 2029
Table 19 : Global Market for Prefilled Syringes for Diabetes, by Region, Through 2029
Table 20 : Global Market for Prefilled Syringes for Cancer, by Region, Through 2029
Table 21 : Global HIV Epidemic, by Age Group, 2021
Table 22 : Global Market for Prefilled Syringes for Infectious Diseases, by Region, Through 2029
Table 23 : Global Market for Prefilled Syringes for Other Disease Treatments, by Region, Through 2029
Table 24 : Global Market for Prefilled Syringes, by Region, Through 2029
Table 25 : Diabetes Estimates in North America, by Country, 2000-2045
Table 26 : Influenza Disease Burden in the U.S., by Age Group, 2019 and 2020 Flu Season
Table 27 : North American Market for Prefilled Syringes, by Material, Through 2029
Table 28 : North American Market for Prefilled Syringes, by Design, Through 2029
Table 29 : North American Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 30 : North American Market for Prefilled Syringes, by Application, Through 2029
Table 31 : North American Market for Prefilled Syringes, by Country, Through 2029
Table 32 : Diabetes Estimates for 10 European Countries, 2000-2045
Table 33 : European Market for Prefilled Syringes, by Material, Through 2029
Table 34 : European Market for Prefilled Syringes, by Design, Through 2029
Table 35 : European Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 36 : European Market for Prefilled Syringes, by Application, Through 2029
Table 37 : European Market for Prefilled Syringes, by Country, Through 2029
Table 38 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
Table 39 : Asia-Pacific Market for Prefilled Syringes, by Material, Through 2029
Table 40 : Asia-Pacific Market for Prefilled Syringes, by Design, Through 2029
Table 41 : Asia-Pacific Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 42 : Asia-Pacific Market for Prefilled Syringes, by Application, Through 2029
Table 43 : Asia-Pacific Market for Prefilled Syringes, by Country, Through 2029
Table 44 : Diabetes Estimates in the RoW, by Country, 2000-2045
Table 45 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 46 : RoW Market for Prefilled Syringes, by Material, Through 2029
Table 47 : RoW Market for Prefilled Syringes, by Design, Through 2029
Table 48 : RoW Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 49 : RoW Market for Prefilled Syringes, by Application, Through 2029
Table 50 : RoW Market for Prefilled Syringes, by Sub-Region, Through 2029
Table 51 : Abbreviations Used in this Report
Table 52 : Report Sources
Table 53 : ARTE Corp.: Company Snapshot
Table 54 : ARTE Corp.: Product Portfolio
Table 55 : Baxter: Company Snapshot
Table 56 : Baxter: Financial Performance, FY 2022 and 2023
Table 57 : Baxter: Product Portfolio
Table 58 : BD: Company Snapshot
Table 59 : BD: Financial Performance, FY 2022 and 2023
Table 60 : BD: Product Portfolio
Table 61 : BD: News/Key Developments, 2021 and 2022
Table 62 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 63 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 64 : F. Hoffmann-La Roche Ltd: Product Portfolio
Table 65 : Gerresheimer AG: Company Snapshot
Table 66 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
Table 67 : Gerresheimer AG: Product Portfolio
Table 68 : Haselmeier: Company Snapshot
Table 69 : Haselmeier: Product Portfolio
Table 70 : Haselmeier: News/Key Developments, 2024
Table 71 : Nipro: Company Snapshot
Table 72 : Nipro: Financial Performance, FY 2022 and 2023
Table 73 : Nipro: Product Portfolio
Table 74 : SHL Medical AG: Company Snapshot
Table 75 : SHL Medical AG: Product Portfolio
Table 76 : SHL Medical AG: News/Key Developments, 2024
Table 77 : Stevanato Group: Company Snapshot
Table 78 : Stevanato Group: Financial Performance, FY 2022 and 2023
Table 79 : Stevanato Group: Product Portfolio
Table 80 : Stevanato Group: News/Key Developments, 2023
Table 81 : Ypsomed: Company Snapshot
Table 82 : Ypsomed: Financial Performance, FY 2022 and 2023
Table 83 : Ypsomed: Product Portfolio

List of Figures

Summary Figure : Global Market for Prefilled Syringes, by Material, 2021-2029
Figure 1 : Prefilled Syringes: Market Dynamics
Figure 2 : Distribution Share of the Five Most Frequent Cancers in Women, 2022
Figure 3 : Distribution Share of the Five Most Frequent Cancers in Men, 2022
Figure 4 : Share of Population Age 65 and Older in G7 Countries, 2021
Figure 5 : Global Shares of Population 65 and Older, by Region, 2016 and 2050
Figure 6 : Global Market for Prefilled Syringes, by Material, 2021-2029
Figure 7 : Global Market for Prefilled Syringes, by Design, 2021-2029
Figure 8 : Global Market for Prefilled Syringes, by Therapeutics, 2021-2029
Figure 9 : Global Market for Prefilled Syringes, by Application, 2021-2029
Figure 10 : Global Market for Prefilled Syringes, by Region, 2021-2029
Figure 11 : Distribution Share of Cancer Diagnoses in Europe, by Gender, 2020
Figure 12 : Global Market Shares for Prefilled Syringes, by Company, 2023
Figure 13 : Pillars of ESG
Figure 14 : Advantages of ESG for Companies
Figure 15 : Global ESG-Adoption Level Across All Industries, 2021 and 2022
Figure 16 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
Figure 19 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 20 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
Figure 22 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
Figure 23 : Nipro: Revenue Share, by Business Unit, FY 2023
Figure 24 : Nipro: Revenue Share, by Country/Region, FY 2023
Figure 25 : Stevanato Group: Revenue Share, by Business Unit, FY 2023
Figure 26 : Stevanato Group: Revenue Share, by Country/Region, FY 2023
Figure 27 : Ypsomed: Revenue Share, by Business Unit, FY 2023
Figure 28 : Ypsomed: Revenue Share, by Country/Region, FY 2023

Prefilled Syringes: Global Markets

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory and Reimbursement Landscape

Chapter 5 Product Pipeline for Prefilled Syringes

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in Prefilled Syringes: An ESG Perspective

Chapter 9 Appendix: Global Prefilled Syringes Market

List of Tables

List of Figures